Full Text
EE108 Cost-Effectiveness Analysis of Abrocitinib Versus Dupilumab for Treatment of Moderate-to-Severe Atopic Dermatitis in Chinese Adults

Abstract

Authors

Y. Jiang C. Zuo Y. Sun J. Qiu H. Bi J. Xuan

Back to Volume 26, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×